These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 6208327

  • 1. Slow orthograde axonal transport of radiolabelled protein in sciatic motoneurones of rats with short-term experimental diabetes: effects of treatment with an aldose reductase inhibitor or myo-inositol.
    Mayer JH, Tomlinson DR, McLean WG.
    J Neurochem; 1984 Nov; 43(5):1265-70. PubMed ID: 6208327
    [Abstract] [Full Text] [Related]

  • 2. Slow component-a of axonal transport, nerve myo-inositol, and aldose reductase inhibition in streptozocin-diabetic rats.
    Tomlinson DR, Sidenius P, Larsen JR.
    Diabetes; 1986 Apr; 35(4):398-402. PubMed ID: 2420664
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Prevention of defects of axonal transport and nerve conduction velocity by oral administration of myo-inositol or an aldose reductase inhibitor in streptozotocin-diabetic rats.
    Mayer JH, Tomlinson DR.
    Diabetologia; 1983 Nov; 25(5):433-8. PubMed ID: 6197336
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The effect of aldose reductase inhibition on the pattern of nerve conduction deficits in diabetic rats.
    Cameron NE, Cotter MA, Robertson S.
    Q J Exp Physiol; 1989 Nov; 74(6):917-26. PubMed ID: 2512591
    [Abstract] [Full Text] [Related]

  • 7. Myo-inositol and sorbitol metabolism in relation to peripheral nerve function in experimental diabetes in the rat: the effect of aldose reductase inhibition.
    Gillon KR, Hawthorne JN, Tomlinson DR.
    Diabetologia; 1983 Oct; 25(4):365-71. PubMed ID: 6416913
    [Abstract] [Full Text] [Related]

  • 8. Increased nerve polyol levels in experimental diabetes and their reversal by Sorbinil.
    Whiting PH, Ross IS.
    Br J Exp Pathol; 1988 Oct; 69(5):697-702. PubMed ID: 3143396
    [Abstract] [Full Text] [Related]

  • 9. Treatment with an aldose reductase inhibitor can reduce the susceptibility of fast axonal transport following nerve compression in the streptozotocin-diabetic rat.
    Dahlin LB, Archer DR, McLean WG.
    Diabetologia; 1987 Jun; 30(6):414-8. PubMed ID: 2445613
    [Abstract] [Full Text] [Related]

  • 10. The effects of aldose reductase inhibition on nerve sorbitol and myoinositol concentrations in diabetic and galactosemic rats.
    Yue DK, Hanwell MA, Satchell PM, Handelsman DJ, Turtle JR.
    Metabolism; 1984 Dec; 33(12):1119-22. PubMed ID: 6438438
    [Abstract] [Full Text] [Related]

  • 11. Axonal transport and tissue contents of substance P in rats with long-term streptozotocin-diabetes. Effects of the aldose reductase inhibitor 'statil'.
    Robinson JP, Willars GB, Tomlinson DR, Keen P.
    Brain Res; 1987 Nov 24; 426(2):339-48. PubMed ID: 2446712
    [Abstract] [Full Text] [Related]

  • 12. Effect of aldose reductase inhibition on nerve conduction velocity and resistance to ischemic conduction block in experimental diabetes.
    Price DE, Airey CM, Alani SM, Wales JK.
    Diabetes; 1988 Jul 24; 37(7):969-73. PubMed ID: 3133261
    [Abstract] [Full Text] [Related]

  • 13. Prevention and reversal of defective axonal transport and motor nerve conduction velocity in rats with experimental diabetes by treatment with the aldose reductase inhibitor Sorbinil.
    Tomlinson DR, Moriarty RJ, Mayer JH.
    Diabetes; 1984 May 24; 33(5):470-6. PubMed ID: 6202576
    [Abstract] [Full Text] [Related]

  • 14. Prevention of defects of axonal transport in experimental diabetes by aldose reductase inhibitors.
    Tomlinson DR, Willars GB, Robinson JP.
    Drugs; 1986 May 24; 32 Suppl 2():15-8. PubMed ID: 2431858
    [Abstract] [Full Text] [Related]

  • 15. Role of sorbitol accumulation and myo-inositol depletion in paranodal swelling of large myelinated nerve fibers in the insulin-deficient spontaneously diabetic bio-breeding rat. Reversal by insulin replacement, an aldose reductase inhibitor, and myo-inositol.
    Greene DA, Chakrabarti S, Lattimer SA, Sima AA.
    J Clin Invest; 1987 May 24; 79(5):1479-85. PubMed ID: 3033025
    [Abstract] [Full Text] [Related]

  • 16. Prevention of defective axonal transport in streptozocin-diabetic rats by treatment with "Statil" (ICI 128436), an aldose reductase inhibitor.
    Tomlinson DR, Townsend J, Fretten P.
    Diabetes; 1985 Oct 24; 34(10):970-2. PubMed ID: 2412918
    [Abstract] [Full Text] [Related]

  • 17. Studies on peripheral nerve and lens in long-term experimental diabetes: effects of the aldose reductase inhibitor statil.
    Willars GB, Townsend J, Tomlinson DR, Compton AM, Churchill RD.
    Metabolism; 1988 May 24; 37(5):442-9. PubMed ID: 2452959
    [Abstract] [Full Text] [Related]

  • 18. Reversal of deficits in axonal transport and nerve conduction velocity by treatment of streptozotocin-diabetic rats with myo-inositol.
    Tomlinson DR, Mayer JH.
    Exp Neurol; 1985 Aug 24; 89(2):420-7. PubMed ID: 2410289
    [Abstract] [Full Text] [Related]

  • 19. The role of cyclic adenosine 3',5'-monophosphate and polyol metabolism in diabetic neuropathy.
    Shindo H, Tawata M, Aida K, Onaya T.
    J Clin Endocrinol Metab; 1992 Feb 24; 74(2):393-8. PubMed ID: 1370506
    [Abstract] [Full Text] [Related]

  • 20. The effects of an aldose reductase inhibitor upon the sorbitol pathway, fructose-1-phosphate and lactate in the retina and nerve of streptozotocin-diabetic rats.
    Poulsom R, Mirrlees DJ, Earl DC, Heath H.
    Exp Eye Res; 1983 May 24; 36(5):751-60. PubMed ID: 6406254
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.